Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

May 24, 2020

Study Completion Date

August 9, 2022

Conditions
Diffuse Large B-Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent
Interventions
DRUG

Loncastuximab tesirine

intravenous infusion

Trial Locations (37)

6500

Anastasios Stathis, Bellinzona

11733

North Shore Hematology Oncology Associates DBA NY Cancer and Blood Specialists, East Setauket

15121

A.O. SS Antonio e Biagio e Cesare Arrigo, Alessandria

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

20089

U.O. Oncologia ed Ematologia, Rozzano

20132

Dipartimento di Oncomatlolgia - Unita Linfomi, Milan

20141

Divisione di Oncoematologia, Milan

22031

Virginia Cancer Specialists, PC, Fairfax

29425

Hollings Cancer Center, Charleston

29605

GHD Cancer Institute, Greenville

30060

Northwest Georgia Oncology Centers, PC-Drug Shipment, Lab and Study Supplies Only, Marietta

30322

Winship Cancer Institute of Emory University, Atlanta

30342

Northside Hospital, Atlanta

33136

University of Miami Hospital and Clinics, Miami

33176

Miami Cancer Institute, Miami

40138

Istituto di Ematologia Seragnoli, Bologna

44106

University Hospitals Cleveland Medical Center, Cleveland

50309

Medical Oncology & Hematology Associates, Des Moines

53226

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

63110

Washington University School of Medicine, St Louis

68198

University of Nebraska Medical Center/ Nebraska Medicine, Omaha

70121

Ochsner Clinic Foundation, New Orleans

75246

Baylor University Medical Center, Dallas

76508

Baylor Scott & White Medical Center - Temple, Temple

90602

The Oncology Institute of Hope and Innovation, Whittier

91010

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte

92093

UC San Diego Moores Cancer Center, La Jolla

92708

Compassionate Care Research Group, Inc., at Compassionate Care Medical Group, Inc., Fountain Valley

94143

University of California, San Francisco Medical Center, San Francisco

98506

Vista Oncology Inc. PS, Olympia

LE1 5WW

University Hospitals of Leicester NHS Trust., Leicester

NW1 2PG

University College London Hospital, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

OX3 7 LE

Oxford Cancer Centre, Churchill Hospital, Oxford

G120YN

NHS Greater Glasgow and Clyde, Glasgow

SA2 8QA

Abertawe Bro Morgannwg University Health Board - Singleton Hospital, Swansea

NG5 1 PB

Nottingham University Hospitals NHS Trust, Nottingham

Sponsors
All Listed Sponsors
lead

ADC Therapeutics S.A.

INDUSTRY